Expression network analysis reveals cord blood vitamin D-associated genes affecting risk of early life wheeze.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 30021811.
- Also identified by DOI 10.1136/thoraxjnl-2018-211962 and PMC identifier 11293338.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cord blood 25-hydroxyvitamin D (25OHD) has been reported in association with risk of early life recurrent wheeze. In a subset of infants who participated in the Vitamin D Antenatal Asthma Reduction Trial, we demonstrated that higher cord blood 25OHD at birth (>31 ng/mL) was associated with a reduced risk of recurrent wheeze in the first year of life. We then identified a module of co-expressed genes associated with cord blood 25OHD levels >31 ng/mL. Genes in this module are involved in biological and immune pathways related to development and progression of asthma pathogenesis including the Notch1 and transforming growth factor-beta signalling pathways.
Medical subject headings
- Asthma
- Fetal Blood
- Respiratory Sounds
- Vitamin D